These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8388594)

  • 1. [The effect of anti-hepatitis immunoglobulins on the intensity of the immunity to the hepatitis A virus].
    Perepelkin VS; Katkov AI; Semenenko TA; Mikhaĭlov MI; Vasil'eva VI
    Voen Med Zh; 1993 Feb; (2):37-8. PubMed ID: 8388594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylactic effectiveness of immunoglobulin preparations with different amounts of specific antibodies to the hepatitis A virus].
    Perepelkin VS; Sumarokov AA; Gorbunov MA; Tiantov GA; Borzykh VA
    Voen Med Zh; 1988 Dec; (12):37-9. PubMed ID: 2853893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the content of hepatitis A antibodies in immunoglobulin preparations on the effectiveness of the immunoglobulin prophylaxis of hepatitis A].
    Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Khalitova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):86-9. PubMed ID: 6087581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific anti-HAV immunoglobulin.
    Goudemand M; Maniez-Montreuil M; Dupressoir-Burlet MV
    Lancet; 1993 Jul; 342(8865):239. PubMed ID: 8100956
    [No Abstract]   [Full Text] [Related]  

  • 5. Type A viral hepatitis. New developments in an old disease.
    Lemon SM
    N Engl J Med; 1985 Oct; 313(17):1059-67. PubMed ID: 2413356
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis A virus antibodies in preparations of normal immunoglobulin of Polish production].
    Loch T; Szubiakiewicz Z; Fiejka M; Halama G; Cichocki P; Brzosko WJ
    Pol Tyg Lek; 1980 Jul; 35(28):1053-4. PubMed ID: 6253962
    [No Abstract]   [Full Text] [Related]  

  • 7. [The possibility of using an indirect method of fluorescent antibodies to the hepatitis A virus in epidemic control practice].
    Perepelkin VS; Polianin VA; Zhukova TM; Nedospelov IuN; Ezhov VA
    Voen Med Zh; 1989 Sep; (9):33-5. PubMed ID: 2556858
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for hepatitis A antibody before prescribing standard immunoglobulin for Europeans staying in tropical areas.
    Larouze B; Gaudebout C; Foulon G; Mercier E; Ancelle JP
    Lancet; 1984 Feb; 1(8374):449-50. PubMed ID: 6142171
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of IgM and IgG antibodies to hepatitis A virus by reversed passive hemagglutination inhibition test].
    Sun YZ
    Zhonghua Yi Xue Za Zhi; 1982 Jun; 62(6):333-5. PubMed ID: 6290007
    [No Abstract]   [Full Text] [Related]  

  • 10. Tourist hepatitis, antibodies to hepatitis A virus and immune serum globulin prophylaxis.
    Iwarson S; Frösner G; Norkrans G
    Infection; 1978; 6(6):257-8. PubMed ID: 215556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The evaluation of the late effect of the multiple administration of immunoglobulin on hepatitis A morbidity in organized collectives].
    Katkov AI; Semenenko TA; Vasil'eva VI
    Voen Med Zh; 1991 Nov; (11):35-7. PubMed ID: 1668550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-hepatitis virus antibodies in hospital personnel].
    Puelma E; Velasco M
    Rev Med Chil; 1983 Oct; 111(10):1033-4. PubMed ID: 6328608
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of immune serum globulin in an outbreak of hepatitis A virus infection in adults.
    Green MS; Dotan K
    J Infect; 1988 Nov; 17(3):265-70. PubMed ID: 2851022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological markers of viral hepatitis in commercial series of immunoglobulin].
    Burlev VA; Gerasun BA
    Vrach Delo; 1983 Nov; (11):112-4. PubMed ID: 6318446
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts.
    Kendall BJ; Cooksley WG
    Drugs; 1991 Jun; 41(6):883-8. PubMed ID: 1715265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active and passive immunization in viral hepatitis A and B].
    Fay O; Pérez V
    Acta Gastroenterol Latinoam; 1982; 12(1):75-87. PubMed ID: 7136456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis, epidemiologic aspects and prevention of hepatitis A].
    Coutinho RA; Duermeyer W
    Ned Tijdschr Geneeskd; 1982 Oct; 126(41):1875-8. PubMed ID: 6292746
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic efficacy of immune serum globulin against hepatitis A.
    Ohara H; Ebisawa I; Ohtani S
    Jpn J Exp Med; 1986 Oct; 56(5):229-33. PubMed ID: 3027432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral hepatitis A: specific immunologic aspects before and after exposure to risk].
    Laverdant C; Hainaut J; Dutertre J
    Bull Acad Natl Med; 1983 Jun; 167(6):619-26. PubMed ID: 6318924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.